Bold items in the following list are styles that will not be carried through to the XML during the Export process. These items are redundant with metadata that is captured in the eXtyles Document Information dialog, but may be required in the Word document to create PDF.

<book-title-group>
<book-title>UNITED STATES</book-title>
<subtitle>TARIFF MEASURES ON CERTAIN GOODS FROM CHINA</subtitle>
</book-title-group>

Document Type is captured as metadata in the eXtyles Document Information dialog.

<custom-meta-group id="meta-main">
<custom-meta><meta-name>DocCountry</meta-name><meta-value>Switzerland and Liechtenstein</meta-value></custom-meta>
<custom-meta><meta-name>Version</meta-name><meta-value>Argentina<value>Revision</meta-value></custom-meta>
</custom-meta-group>

<book-meta>
<subj-group subj-group-type="report-date-range"><subject>(MID-OCTOBER 2019 TO MID-MAY 2020)</subject></subj-group>
</book-meta>

<contrib<front-groupmatter>
content-type="Authors">
<contrib>
<name name-style="western"><surname>Hill</surname><given-names>Shannon</given-names></name>
</contrib> 
<contrib>
<name name-style="western"><surname>McCormack</surname><given-names>Suzanne</given-names></name>
</contrib>
</contrib-group>

<front-matter-part book-part-type="boilerplateSUMMARY">
<named-book<book-part-body>
<p><bold>Cite As:</bold> Body weight modification interventions for chronic non-cancer pain: a review of clinical 
effectiveness. Ottawa: CADTH; 2020 Mar. (CADTH rapid response report: summary with critical appraisal).</p>
<p><bold>ISSN:</bold> 1922-8147 (online)</p>
<p><bold>Disclaimer:</bold> The information in this document is intended to help Canadian health care decision-makers, 
health care professionals, health systems leaders, and policy-makers make well-informed decisions and thereby improve the 
quality of health care services. While patients and others may access this document, the document is made available for 
informational purposes only and no representations or warranties are made with respect to its fitness for any particular 
purpose. The information in this document should not be used as a substitute for professional medical advice or as a 
substitute for the application of clinical judgment in respect of the care of a particular patient or other professional 
judgment in any decision-making process. The Canadian Agency for Drugs and Technologies in Health (CADTH) does not endorse 
any information, drugs, therapies, treatments, products, processes, or services.</p>meta>
<title-group>
<title>SUMMARY</title>
</title-group>
</book-part-meta>
<named-book-part-body>
<p>1. The trade regimes of Switzerland and Liechtenstein remain generally open, except in agriculture, which continues to be protected with high import tariffs levied on sensitive products. Switzerland and Liechtenstein continue to be strong supporters of a rules-based multilateral trading system and, during difficult times for the global economy, they advocate further trade liberalization. The last joint TPR of Switzerland and Liechtenstein took place in 2013.</p>

<def-list list-type="simple" list-content="abbreviations">
<title>Abbreviations</title>
<def-item><term>AE</term><def><p>adverse event</p></def></def-item>
<def-item><term>AGI</term><def><p>Ahmed glaucoma implant</p></def></def-item>
<def-item><term>ALT</term><def><p>argon laser trabeculoplasty</p></def></def-item>
<def-item><term>BGI</term><def><p>Baerveldt glaucoma implant</p></def></def-item>
<def-item><term>BCVA</term><def><p>best-corrected visual acuity</p></def></def-item>
...

<glossary id="glossary1">
<title>Glossary</title>
<p>The economic analysis in this report uses a four-letter acronym convention to label the screening strategies. Each letter corresponds to a type of screening scheduled at each of the trimesters and during labour and delivery in a chronological order; whereby, the first letter corresponds to the first trimester, the second letter corresponds to the second trimester, the third letter corresponds to the third trimester, and the fourth letter corresponds to labour and delivery. Each letter is coded in the following manner:</p>
<def-list list-content="glossary">
<def-item><term><bold>N</bold></term><def><p>no screening</p></def></def-item>
<def-item><term><bold>M</bold></term><def><p>mixed screening of age-based subgroups of the pregnant population (i.e., those who are younger than 25 years and those who are 25 years or older) based on other criteria (e.g., prior screening history).</p></def></def-item>
<def-item><term><bold>T</bold></term><def><p>age-targeted screening; whereby, only the pregnant population that included those who are younger than 25 years are screened.</p></def></def-item>
<def-item><term><bold>U</bold></term><def><p>universal screening</p></def></def-item>
</def-list>
<p>For example, screening strategy TNUM would indicate age-targeted screening in the first trimester, no screening in the second trimester, universal screening in the third trimester, and mixed screening during labour and delivery.</p>
</glossary>